Quest Diagnostics, Inc. (DGX) Tops Q1 EPS by 6c; Raises FY12 Outlook
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $203.06 -0.38%
EPS Growth %: +7.6%
Financial Fact:
Amortization of intangible assets: 18M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: +7.6%
Financial Fact:
Amortization of intangible assets: 18M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Quest Diagnostics, Inc. (NYSE: DGX) reported Q1 EPS of $1.07, $0.06 better than the analyst estimate of $1.01. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.88 billion.
Raises its FY12 EPS guidance to $4.45-$4.60, which compares to the Street estimate of $4.54. The company previously guided to $4.40-$4.55.
For earnings history and earnings-related data on Quest Diagnostics, Inc. (DGX) click here.
Raises its FY12 EPS guidance to $4.45-$4.60, which compares to the Street estimate of $4.54. The company previously guided to $4.40-$4.55.
For earnings history and earnings-related data on Quest Diagnostics, Inc. (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- MIND Technology (MIND) Misses Q1 EPS by 5c
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
